These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1522668)
1. [In vitro study on efficacy of combination use of aspoxicillin and beta-lactam preparations (ceftazidime, cefmetazole and aztreonam) against bacteria isolated from abdominal infections]. Chimura T; Ise H; Misawa H Jpn J Antibiot; 1992 Jul; 45(7):763-73. PubMed ID: 1522668 [TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of combination therapy with aspoxicillin and ceftazidime for severe infections complicating hematological disorders]. Akasaka K; Nasu K; Horiuchi A; Hasegawa H; Tatsumi N; Nin Y; Kitani T; Taniguchi N; Tagawa S; Mosaoka T Jpn J Antibiot; 1990 Sep; 43(9):1614-20. PubMed ID: 2262966 [TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of clinical isolates to aztreonam]. Asari S; Horikawa M; Tsukamoto H; Kouda K; Hayashi C; Miyai K Jpn J Antibiot; 1987 Jul; 40(7):1317-31. PubMed ID: 3479624 [TBL] [Abstract][Full Text] [Related]
4. [A clinical study on the efficacy of ceftazidime alone or in combination with aspoxicillin against infections in obstetric and gynecological patients]. Chimura T; Hirayama T; Funayama T; Nara N; Miyata R; Kanasugi H; Sato S; Oda T; Saito N; Morisaki N Jpn J Antibiot; 1993 Sep; 46(9):827-35. PubMed ID: 8254902 [TBL] [Abstract][Full Text] [Related]
5. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2002]. Abe T; Sato Y; Sei M Jpn J Antibiot; 2003 Dec; 56(6):574-83. PubMed ID: 15007873 [TBL] [Abstract][Full Text] [Related]
6. [A clinical study on the efficacy of ceftazidime and aspoxicillin in chorioamnionitis. Abdominal Infections Research Group]. Chimura T; Hirayama T; Oda T; Saito N; Sato S; Numazaki M Jpn J Antibiot; 1994 Sep; 47(9):1210-8. PubMed ID: 7990262 [TBL] [Abstract][Full Text] [Related]
7. Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole. Dubreuil LJ; Mahieux S; Neut C; Miossec C; Pace J Int J Antimicrob Agents; 2012 Jun; 39(6):500-4. PubMed ID: 22521766 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations. Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674 [TBL] [Abstract][Full Text] [Related]
9. Carumonam's in-vitro activity against gram-negative bacteria and its stability to their beta-lactamases. Raimondi A; Mattina R; Cocuzza CE Chemioterapia; 1988 Feb; 7(1):3-9. PubMed ID: 3288365 [TBL] [Abstract][Full Text] [Related]
10. Effect of aspoxicillin on anaerobic bacteria. Ueno K; Watanabe K; Bunai M; Kobayashi T; Aoki M; Maezawa I; Sakuma Y; Yoshida H; Yamaguchi T Jpn J Antibiot; 1985 Jun; 38(6):1516-28. PubMed ID: 3850132 [TBL] [Abstract][Full Text] [Related]
11. [Combination antibacterial effects between aztreonam and eight other antibiotics]. Nishino T; Obana Y; Kuzui H; Murakami T Jpn J Antibiot; 1991 Jan; 44(1):1-8. PubMed ID: 1904106 [TBL] [Abstract][Full Text] [Related]
12. [Urinary tract infection associated with urinary calculi. 2. Effects of antibiotics on bacteria within infected stones]. Takeuchi H; Okada Y; Yoshida O; Konishi T; Tomoyoshi T; Nakahara S Hinyokika Kiyo; 1989 May; 35(5):755-61. PubMed ID: 2801373 [TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activities of aspoxicillin of fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Apr; 46(4):295-309. PubMed ID: 8515561 [TBL] [Abstract][Full Text] [Related]
14. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290 [TBL] [Abstract][Full Text] [Related]
15. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci]. Hara T; Araake M; Tsuruoka T; Watabe H Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activities of monobactams against fresh clinical isolates]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297 [TBL] [Abstract][Full Text] [Related]
18. [Fundamental and clinical studies on aspoxicillin in the pediatric field]. Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M Jpn J Antibiot; 1985 Jul; 38(7):1868-81. PubMed ID: 3851860 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Aktaş Z; Kayacan C; Oncul O Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508 [TBL] [Abstract][Full Text] [Related]
20. [A clinical study of combined therapy of aspoxicillin and ceftazidime on intractable respiratory infections]. Yamaki K; Suzuki R; Taki F; Takagi K; Satake T; Mizuno K; Baba K; Aihara H; Mori M; Yamada K Jpn J Antibiot; 1992 Oct; 45(10):1282-94. PubMed ID: 1479680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]